If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Antonino Bruno is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Neoplasms Medicine & Life Sciences
Natural Killer Cells Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Humulus Medicine & Life Sciences
Carbon Nanotubes Medicine & Life Sciences
Inflammation Medicine & Life Sciences
Polyphenols Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2011 2019

Open Access
Natural Killer Cells
Tumor Microenvironment
Neoplasms
HLA-G Antigens
Phenotype
Drug Repositioning
Phytochemicals
Dietary Supplements
Chronic Disease
Chemoprevention

Validation of the Italian version of carers' quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy

Picillo, M., Cuoco, S., Amboni, M., Bonifacio, F. P., Bruno, A., Bruschi, F., Cappiello, A., De Micco, R., De Rosa, A., Di Biasio, F., Elifani, F., Erro, R., Fabbri, M., Falla, M., Franco, G., Frosini, D., Galantucci, S., Lazzeri, G., Magistrelli, L., Malaguti, M. C. & 23 others, Milner, A. V., Minafra, B., Olivola, E., Pilotto, A., Rascunà, C., Rizzetti, M. C., Schirinzi, T., Borroni, B., Ceravolo, R., Di Fonzo, A., Lopiano, L., Marchese, R., Mercuri, N. B., Modugno, N., Nicoletti, A., Padovani, A., Santangelo, G., Stefani, A., Tessitore, A., Volontè, M. A., Zangaglia, R., Zappia, M. & Barone, P., 2019, In : Neurological Sciences. 40, (10), p. 2163-2169 7 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Parkinsonian Disorders
Caregivers
Quality of Life
Multiple System Atrophy

Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy

Picillo, M., Cuoco, S., Amboni, M., Bonifacio, F. P., Bruno, A., Bruschi, F., Cappiello, A., De Micco, R., De Rosa, A., Di Biasio, F., Elifani, F., Erro, R., Fabbri, M., Falla, M., Franco, G., Frosini, D., Galantucci, S., Lazzeri, G., Magistrelli, L., Malaguti, M. C. & 23 others, Milner, A. V., Minafra, B., Olivola, E., Pilotto, A., Rascunà, C., Rizzetti, M. C., Schirinzi, T., Borroni, B., Ceravolo, R., Di Fonzo, A., Lopiano, L., Marchese, R., Mercuri, N. B., Modugno, N., Nicoletti, A., Padovani, A., Santangelo, G., Stefani, A., Tessitore, A., Volontè, M. A., Zangaglia, R., Zappia, M. & Barone, P., Oct 1 2019, In : Neurological Sciences. 40, 10, p. 2163-2169 7 p.

Research output: Contribution to journalArticle

Progressive Supranuclear Palsy
Parkinsonian Disorders
Caregivers
Quality of Life
Multiple System Atrophy

Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways

Baci, D., Bruno, A., Bassani, B., Tramacere, M., Mortara, L., Albini, A. & Noonan, D. M., Aug 10 2018, In : Cancer Letters. 429, p. 100-116 17 p.

Research output: Contribution to journalArticle

Acetylcarnitine
Carnitine
Prostatic Neoplasms
Endothelial Cells
Neoplasms